Tumor cell migration is a well-orchestrated multistep process that drives cancer development and metastasis. Previous data indicated that CD146 expression correlates with malignant progression and metastatic potential of human melanoma cells. However, the exact molecular mechanism of how CD146 promotes melanoma cell migration still remains poorly understood. Here, we report that CD146 physically interacts with actin-linking ezrin-radixin-moesin (ERM) proteins and recruits ERM proteins to cell protrusions, promoting the formation and elongation of microvilli. Moreover, CD146-promoted melanoma cell migration is linked to RhoA activation and ERM phosphorylation. CD146 recruits Rho guanine nucleotide dissociation inhibitory factors 1 (RhoGDI1) through ERM proteins and thus sequesters RhoGDI1 from RhoA, which leads to upregulated RhoA activity and increased melanoma cell motility. CD146-activated RhoA also promotes further ERM phosphorylation and activation through Rho-phosphatidylinositol-4-phosphate-5-kinase-phosphatidylinositol 4,5-biphosphate pathway, which reinforces CD146/ERM association. Thus, our results provide a mechanistic basis to understand the role of CD146 in regulating human melanoma cell motility.
Introduction
Associations of transmembrane proteins with the cell cytoskeleton through their cytoplasmic tails regulate cell adhesion, migration, invasion, cortical morphogenesis and other plasma membrane processes (Luna and Hitt, 1992; Raucher et al., 2000; McClatchey and Fehon, 2009 ). Among these adaptor proteins mediating such associations, the highly conserved ezrin-radixin-moesin (ERM) proteins are crucial components that provide a regulatable link between membrane-associated proteins and the cortical cytoskeleton, and also participate in signal transductions (Bretscher et al., 2002; McClatchey, 2003) . ERM proteins bind to the plasma membrane receptors at their NH 2 -terminal (NT) domains and to F-actin at their COOH-terminal (CT) domains (Bretscher et al., 1997; Tsukita and Yonemura, 1999) . By inhibitory self-association through intra-or intermolecular head-to-tail interactions between the NT and CT domains, several active binding sites on ERM proteins are masked. The activation process, a conformational change of the protein structure, is tightly regulated by the phosphorylation of a conserved threonine residue in the CT domain of each ERM protein (Louvet-Vallee, 2000) . This phosphorylation is an important step in ERM protein activation, which disrupts the intramolecular interaction. Subsequently, activated ERM proteins are translocated from the cytosol to the membrane-cytoskeleton interface. Moreover, binding of phosphatidylinositol 4,5-biphosphate (PIP 2 ) to the NT domain is a prerequisite for ERM proteins to be phosphorylated and activated (Bretscher et al., 2000; Gervais et al., 2008) . Functionally, ERM proteins have been implicated in signifying specialized membrane domains, promoting cell cytoskeleton remodeling and Rho GTPase activation, and inducing signal transduction (Bretscher et al., 2000) . Several studies have also provided evidence that ERM expressions correlated with cell polarization, cell-cell or cell-ECM communication, and tumor cell transformation, motility and metastasis (Bretscher et al., 2002; McClatchey, 2003) .
GDP dissociation inhibitors (GDIs) are important regulators of Rho GTPase function, which is involved in cell movements (DerMardirossian and Bokoch, 2005; Dovas and Couchman, 2005) . GDIs inhibit dissociation of GDP from Rho proteins, preventing their conversions to the active, GTP-bound forms that are translocated to the membrane. In addition, by interacting with the active, GTP-bound form of Rho GTPase, GDIs also inhibit GTP hydrolysis, blocking both intrinsic GTPase activity and interactions of Rho proteins with effector molecules (Olofsson, 1999) . Therefore, GDIs modulate the cycling of Rho GTPases between cytosol and membranes. Importantly, RhoG-DI1 was found to associate with a protein complex containing ERM proteins and CD44, which might be important for cell cytoskeleton remodeling and cell motility (Hirao et al., 1996) . CD146, also known as MCAM, MUC18, A32 antigen and S-Endo-1, was initially identified as a melanoma marker . It is an integral membrane glycoprotein and belongs to the immunoglobulin superfamily. Its ectodomain contains five immunoglobulin-like domains and its cytoplasmic tail contains potential protein kinase C recognition sites and PDZ binding sites (Guezguez et al., 2006) , indicating possible involvements in cell signaling. Although the extracellular ligand for CD146 is still unidentified, several studies have validated its functions in mediating the transduction of outside-in signals (Ouhtit et al., 2009) . Anfosso et al. (1998) found that CD146 crosslinking by a monoclonal antibody (mAb), named Sendo1, triggers the phosphorylation of FAK through association with Fyn. Moreover, our previous works revealed that CD146 mediates tumor secretion-induced p38/IkB kinase/nuclear factor-kB signaling cascade, which is pivotal in inducing endothelial cell activation, leading to tumor angiogenesis (Yan et al., 2003; Bu et al., 2006; Zheng et al., 2009) . Nevertheless, fully understanding of CD146 signaling relies on the identifications of not only the ligand, but also intracellular binding partners and effectors.
Several lines of evidence suggested that CD146 expression is upregulated in various types of experimental and clinical tumors, including melanoma (Shih et al., 1994; Johnson et al., 1997) , prostate cancer (Wu et al., 2001 (Wu et al., , 2004 , epithelial ovarian cancer (Aldovini et al., 2006) , non-small-cell lung cancer (Kristiansen et al., 2003) and mesothelioma (Bidlingmaier et al., 2009) . More importantly, ectopic expression of CD146 in melanoma was found in a positive correlation with tumorigenic transformation and the development of metastatic potential in both mice models and clinical data (Luca et al., 1993; Li et al., 2002) . However, the underlying molecular mechanism of how CD146 promotes melanoma cell migration has not been elucidated yet. We reason that identifying signaling molecules downstream of CD146 would provide mechanistic clues. In this study, we find that CD146 physically interacts with ERM proteins and then recruits RhoGDI1 through ERM proteins. By using two human melanoma cell lines with different CD146 levels, A375 (CD146 high ) and SK-mel-28 (CD146 low ), we show the potential roles of CD146/ERM complex in inducing RhoA activation, ERM phosphorylation and human melanoma cell migration.
Results

CD146 associates with moesin and actin cytoskeleton
To understand the mechanism of how CD146 regulates cell movements, we searched for potential CD146-associated proteins using immunoprecipitation and proteomic analysis. Both b-actin and moesin were co-precipitated with endogenous CD146 and identified in mass spectrometric analysis ( Figure 1a) . As moesin is a membrane-cytoskeleton linker protein belonging to the ERM (ezrin-radixin-moesin) protein family, these results indicated that CD146 might be linked to the actin filament through moesin.
The association of endogenous CD146 with moesin was then verified by co-immunoprecipitation in four melanoma cell lines, A375, CD146 (Figures 1b and c) . To further confirm the specific interaction between CD146 and moesin, particularly the N-terminal domain of moesin (designated as NT domain or moesin-FERM), we transfected moesin or moesin-FERM-expressing plasmids into HEK293T cells stably expressing human CD146. As the original HEK293T cells do not express CD146, the reconstitution of CD146/moesin complex served as evidence for possibly direct interaction (Figure 1d ). Furthermore, glutathione S-transferase (GST) pull-down assays showed that GST-CD146cyt, CD146 cytoplasmic domain fused with GST, was readily bound by His-tagged moesin-FERM, whereas neither GST nor GST-beads exhibited this property (Figure 1e ), demonstrating a direct physical interaction between CD146 cytosolic tail and moesin NT domain. It is worth noting that ezrin and radixin, the other two ERM family members, were also found associated with CD146 in melanoma A375 cells (Supplementary Figure S1) , demonstrating the common ability of ERM proteins to link CD146 with actin cytoskeleton.
Moesin Thr558 phosphorylation is required for CD146/ moesin association As only the phosphorylated ERM adopting the active conformation associates with the cytoplasmic tails of membrane proteins, we further studied the association between CD146 and p-ERM by confocal microscopy analysis. CD146 was found colocalized with p-ERM on the cell membrane and with actin filament at submembranous F-actin cytoskeleton (Figure 2a ). These images supported that p-ERM proteins function as linkers between membrane protein CD146 and actin cytoskeleton.
We next asked whether the association of CD146 with moesin requires its CT domain phosphorylation by transfecting A375 cells with plasmids expressing various GFP-tagged moesin mutants (Figure 2b ). The expression of various GFP-tagged moesin mutants was confirmed by western blot using anti-ERM 38/87 and anti-GFP antibody (Supplementary Figure S2) . Wildtype (WT) moesin-GFP was preferentially localized at the peripheral membrane; however, the unphosphorylatable moesin mutant T558A was distributed diffusely in the cytoplasm rather than concentrated on the cell membrane. In marked contrast, mutant T558D, which constitutively adopts the active configuration, was exclusively accumulated at the cell membrane and intensively colocalized with membrane-bound CD146 (Figure 2b ). The fluorescent signal of the NT domain fragment tagged with GFP was also detected at the membrane, similar to the constitutively active form of moesin. These data implied that Thr558 phosphorylation CD146 , by immunoblot. CD146-negative melanoma cell line MALME-3M served as a negative control. (c) Co-IP assays for association of endogenous CD146 with ERM and b-actin proteins in four human melanoma cell lysates. CD146 was precipitated by mAb AA98, and immunoblot was performed to analyze the immunoprecipitates. (d) Co-IP assays for association of CD146 with moesin and moesin-FERM in CD146-expressing HEK293T cells. Cells were transfected with Flagmoesin or Flag-moesin-FERM. Proteins were precipitated by anti-Flag mAb M2, and examined by immunoblot using antibodies against CD146. (e) Direct interaction between CD146 cytoplasmic tail and moesin-FERM in vitro. Proteins were expressed in E. coli and subjected to GST pull-down assays. His-moesin-FERM and GST-CD146cyt proteins were detected by immunoblot using anti-His or anti-GST antibody. Purified His-moesin-FERM and GST-CD146cyt proteins were loaded as the input lane.
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Y Luo et al of moesin, which leads to the open conformation, could be indispensable for CD146/moesin association. Biochemical analysis further confirmed the association of CD146 with moesin adopting active structures. Interactions between CD146 and WT, T558D or NT moesin were readily detected by co-immunoprecipitation, whereas interaction between CD146 and T558A moesin was undetectable (Figure 2c ). b-Actin was strongly co-precipitated with CD146 only in WT and T558D moesin transfectants, but not in NT and T558A moesin transfectants. These findings demonstrated that Thr558 phosphorylation and the subsequent conformational changes of moesin are required for the bridging between actin filament and membrane CD146.
Positively charged KKGK motif is responsible for the firm interaction of CD146 with moesin To further address the details of CD146/ERM interaction, we performed computational analyses and discovered a conserved positively charged amino-acid cluster KKGK motif in the juxtamembrane region of CD146 cytoplasmic tail, which might serve as a potential binding site for ERM proteins. To test this hypothesis, various CD146 mutants ( Figure 3a) were co-expressed with WT moesin, respectively, in HEK293T cells and the reconstituted association between the two proteins was tested. Results showed almost equivalent moesin binding signal for WT CD146 and CD146-KKGKLP with Myctagged moesin, but only a faint signal for the CD146-DKKGK mutant (Figure 3b) , which lacks the positively charged KKGK motif. Furthermore, ezrin and radixin also showed strong binding signals with WT CD146 and CD146-KKGKLP, but not CD146-DKKGK (Supplementary Figure S3 ), indicating that the juxtamembrane KKGK motif is required for the firm association of CD146 with ERM proteins.
Interestingly, in an in vitro binding assay, mAb AA14, which is raised against CD146 cytoplasmic domain and Figure S4) , was capable of significantly suppressing the binding of recombinant GST-CD146cyt to ERM proteins ( Figure 3c ). In contrast, both anti-CD146 mAb AA1 that does not recognize the KKGK motif and the normal mouse immunoglobulin G did not affect the binding of CD146 to moesin. These data further supported that the KKGK motif within CD146 juxtamembrane region is indispensable for forming CD146/moesin complex.
Functional moesin is required for CD146-induced melanoma cell migration As moesin is thought to be important for actin cytoskeleton rearrangement (Niggli and Rossy, 2008) , we then tested the role of moesin in melanoma cell migration. It was found that the constitutively active moesin T558D mutant enhanced the transmigration of melanoma A375 ( Figure 4a ) and SK-mel-28 ( Figure 4b ) cells, whereas ectopic expression of T558A moesin led to a decrease of cell motility. However, overexpression of WT moesin had little effect on it, suggesting that the activation or phosphorylation of moesin rather than its protein level is mainly responsible for the increased cell motility. Moreover, cells expressing NT moesin showed remarkably diminished migration, indicating that the N-terminal domain alone acts in a dominant-negative manner to inhibit the endogenous ERM proteins by competing for the binding of membrane proteins. These results obtained in melanoma cells are consistent with previous observations for the functions of moesin in mediating cytoskeleton rearrangement and modulating cell migrations (Lee et al., 2004) .
It has been previously found that CD146 could significantly promote human melanoma cell migration (Shih et al., 1994; Johnson et al., 1997) . Therefore, we next assessed whether moesin is the downstream effector responsible for CD146-induced cell motility enhancement. In the presence of dominant-negative moesin mutant, moesin-FERM or moesin-T558A, neither CD146 overexpression nor CD146 knockdown could affect A375 cell migration any longer (Figures 4c and d, expressions were confirmed by western blot in Supplementary Figure S5 ). Same results were obtained in SKmel-28 cells (Supplementary Figure S6) . These data suggested that moesin is indispensible for CD146-promoted melanoma cell migration. More interestingly, knockdown of CD146 blocked the ability of constitutively active moesin T558D to drive cell migration (Figure 4e ), indicating that the function of moesin also heavily relies on the presence of CD146. This result hinted that CD146 might be an essential membrane protein responsible for recruiting ERM and cytoskeleton during cell migration in melanoma.
As the formation of microvilli-like membrane protrusions is a very important characteristic for migrating cells (Crepaldi et al., 1997; Barreiro et al., 2004) , we then tested the localizations of CD146 and ERM proteins on the microvilli-like minute projections of A375 cells. Interestingly, laser scanning confocal microscopy analysis showed a nearly perfect colocalization of CD146-RFP with moesin-GFP on A375 microvilli displayed in GST or GST-CD146cyt beads were incubated with A375 lysate in the presence of purified mAb AA14, AA1 or mouse immunoglobulin GG (100 mg/ml) for 60 min at 4 1C, followed by centrifugation and extensive washing. ERM proteins bound to GST-CD146cyt or GST were detected by immunoblot with anti-ERM mAb 38/87. Approximately 20 ml A375 cell lysate was loaded as the input lane. GST and GST-CD146cyt bound to the beads were detected by immunoblot with anti-GST antibody.
Y Luo et al the merged channel ( Figure 4f ). Sequential optical sections of a defined region displayed a wide and significant overlapping of the CD146 with moesin fluorescent signals specifically in the membrane protrusions ( Figure 4g ). However, neither moesin-FERM nor moesin-T558A could be observed in these membranous protrusions and overexpression of them severely impaired microvilli formation, featured as much less and shorter branchlets or filopodia-like protrusions ( Figure 4h ). These data indicated that the intact structure and open conformation of moesin is required for appropriate local cytoskeleton rearrangement. Importantly, silencing CD146 expression by small interfering RNA (siRNA) significantly disturbed the normal distribution of WT moesin and disrupted the organization of microvilli-like structures (Figure 4h ), suggesting that CD146 may serve critical functions in recruiting moesin, remodeling local actin filaments and CD146 induces ERM phosphorylation through RhoA activity Rho family of small GTPases are believed to regulate ERM protein functions by facilitating the phosphorylation of ERM CT domain, which leads to the disruption of self-association and release of membrane-binding NT domain (Bretscher et al., 2002; McClatchey, 2003) . Here, we found that ectopic expression of a dominantnegative mutant of RhoA, RhoA-19N, remarkably suppressed the phosphorylation of ERM proteins and abolished the association between moesin and CD146 in SK-mel-28 cells (Figures 5a and b) . Moreover, C3 transferase, which specifically ribosylates RhoA and renders it inactive, also significantly blocked ERM phosphorylation ( Figure 5c ). These results indicated that RhoA GTPase activity is crucial for activating moesin and inducing CD146/ERM interaction. Unexpectedly, overexpression of CD146 was able to increase the phosphorylation level of ERM proteins apparently, but this enhancement was completely blocked by the treatment of C3 transferase (Figure 5c ) or the overexpression of RhoA-19N (Figure 5d ) in SKmel-28 cells. In A375 cells, which have a relatively high CD146 interacts with ERM in cell migration Y Luo et al CD146 level, knockdown of CD146 by RNA interference almost completely diminished ERM phosphorylation, whereas the subsequent restoration of CD146 expression rescued the p-ERM level in a RhoAdependent manner (Figure 5e ). Moreover, a correlation between the amount of CD146 protein and the p-ERM level was observed in five independent melanoma cell lines (Figure 1b) . Functionally, the ability of CD146 to promote melanoma cell migration also requires RhoA activity, as CD146 overexpression was unable to increase cell motility if endogenous RhoA was inhibited by C3 transferase or RhoA-19N (Figure 5f ). Similar results were obtained in both A375 and SK-mel-28 cells. Therefore, these data interestingly indicated that CD146 could enhance the phosphorylation of ERM through RhoA GTPase, and RhoA has an important role in mediating CD146-induced melanoma cell migration by activating ERM proteins. Importantly, these results are consistent with previous findings that Rho GTPases mediate cytoskeleton rearrangement and contribute to cancer cell migration (Masiero et al., 1999; Worthylake and Burridge, 2003; Gadea et al., 2007) .
RhoA-PI4P5K-PIP 2 pathway mediates CD146-induced ERM activation
At the downstream of RhoA, Ser/Thr kinases Rhoassociated coiled-coil protein kinase (ROCK) and phosphatidylinositol-4-phosphate-5-kinase (PI4P5K) have been shown to regulate ERM phosphorylation and its interactions (Shibasaki et al., 1997; Matsui et al., 1999; Saci and Carpenter, 2005) . Moreover, Rho-PI4P5K-PIP 2 pathway is responsible for continuous activation of ERM proteins. PI4P5K synthesizes PIP 2 and accumulates it on the membrane, and binding of PIP 2 to ERM proteins is a prerequisite for their phosphorylation and activation (Mangeat et al., 1999; Tsukita and Yonemura, 1999) .
Therefore, we next used chemical inhibitors to test which kinase is involved in regulating ERM activity and CD146/ERM association in melanoma cells. ERM activation level was assayed by measuring the ratio of ERM proteins presented in the insoluble membraneassociated fraction of cell lysates to that in the soluble fraction. We found both neomycin, an inhibitor of PIP 2 , and C3 transferase were able to considerably suppress ERM activation, whereas the ROCK inhibitor, Y27632, had little effect (Figure 6a ). Moreover, only neomycin but not Y27632 could markedly abolish the association between CD146 and ERM proteins (Figure 6b ). These data indicated that PIP 2 is required for activating ERM and maintaining CD146/ERM interaction.
As PIP 2 is synthesized by PI4P5K, we used specific siRNA duplex against PI4P5K to show it is indeed involved in the activation of ERM. Knockdown of (Figures 6c and d) . Same results were also obtained in SK-mel-28 cells (Supplementary Figure S7) . These data suggested that PI4P5K is the essential effector kinase downstream of RhoA GTPase, and RhoA-PI4P5K-PIP 2 cascade is responsible for activating ERM proteins and inducing CD146/ERM association. Importantly, the same pathway is also required for CD146-induced ERM activation, as overexpression of CD146 could no longer enhance membrane translocation or phosphorylation of ERM in the presence of RhoA inhibitors or PIP 2 inhibitors or PI4P5K-specific siRNA (Figures 6a and c) .
CD146/ERM association is required for CD146-induced
RhoA activation and melanoma cell migration The involvement of RhoA in CD146-induced ERM phosphorylation led us to investigate whether CD146 could directly induce the RhoA activation, which in turn regulates ERM proteins, in melanoma cells. Biochemical Rhotekin-Rho-binding domain (RBD) pull-down assay was used to analyze the activation state of RhoA by specifically measuring the level of GTP-bound RhoA proteins. The method was first verified by the observation that C3 transferase completely abrogated the activation of RhoA (Supplementary Figure S8) . We found a close correlation between CD146 expression levels and the levels of active RhoA-GTP and p-ERM in SK-mel-28 cells, which indicated that CD146 indeed promotes ERM phosphorylation through inducing RhoA activation (Figure 7a ).
More interestingly, the ability of CD146 to activate RhoA requires its physical interaction with ERM proteins. Western blot results showed that CD146-DKKGK, which lacks the ERM-binding motif, was unable to upregulate either RhoA activation or ERM phosphorylation level, whereas CD146-KKGKLP could significantly increase the levels of RhoA-GTP and p-ERM (Figures 7b and c) . Moreover, dominant-negative moesin T588A and FERM blocked CD146-induced RhoA activation, meaning that the recruitment of functional ERM to CD146 is essential for activating RhoA (Figure 7d ). These data suggested that CD146 could activate the RhoA GTPase by interacting with ERM proteins and therefore induce further ERM phosphorylation and activation.
Given the finding that the moesin-binding KKGK motif is not only needed for recruiting moesin, but also critical for activating RhoA, we next examined the importance of this motif in promoting cell migration. By testing the transmigration capabilities of the melanoma cells transfected with CD146-wt, CD146-KKGKLP or CD146-DKKGK, we found that loss of KKGK motif significantly diminished the function of CD146 in enhancing cell migration in both A375 and SK-mel-28 cells (Figures 7e and f) . More importantly, CD146 mutant having only the KKGK motif in the cytoplamic tail is sufficient to induce RhoA activation and promote cell migration, suggesting that the function of CD146 in initiating cellular signaling may entirely rely on its interaction with ERM proteins.
These results together indicated that the interaction between CD146 and ERM proteins not only links CD146 to actin filaments, but also initiates a signaling cascade, which activates RhoA-PI4P5K-PIP 2 pathway, leading to the activation of more ERM proteins, strengthening of CD146 anchorage to cytoskeletons and eventually cell movements.
CD146/ERM complex associates with RhoGDI1 and promotes RhoA activation
Although it was found that CD146 could induce RhoA activation through recruiting moesin, the mechanism of how CD146/ERM complex activates RhoA was still unexplored. The activation of Rho is known to be mediated by three distinct functional classes of regulatory proteins, namely Rho guanine nucleotide exchange factors, Rho GTPase-activating proteins and RhoGDIs (Oleksy et al., 2006; Ridley, 2006; Boureux et al., 2007) . By re-examining the CD146/ERM complex in A375 and SK-mel-28 cells, we found that CD146 was also coimunoprecipitated with RhoGDI1 (Figure 8a ). Subsequent confocal microscope analysis showed very clear fluorescent colocalization of CD146 with RhoGDI1 on the membrane of A375 cells (Figure 8b) . Moreover, the CD146/RhoGDI1 interaction was also confirmed in other two melanoma cell lines, Mel-624 and Mel-888 CD146 (data not shown), indicating that the association might be common and conserved in human melanoma cells.
We then tested whether the binding of RhoGDI1 to CD146 requires functional ERM proteins. It was found that the interaction between RhoGDI1 and CD146 was markedly diminished in cells expressing dominantnegative moesin T558A and severely impaired in the presence of moesin-FREM (Figure 8c) . Moreover, interactions between RhoGDI1 and moesin T588D were also directly detected by co-immunoprecipitation, 
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Y Luo et al whereas RhoGDI1 did not bind to inactive moesin T588A, implying that an active conformation of moesin is needed for RhoGDI1/ERM interaction (Figure 8d ). However, RhoGDI1 also bound to the FERM domain of moesin alone, although the binding was not as strong as its association with moesin T588D (Figure 8d) . The results interestingly indicated that although the NT domain of moesin has RhoGDI1 binding site, it might CD146 interacts with ERM in cell migration Y Luo et al be insufficient to mediate CD146/RhoGDI1 interaction, whereas the C terminus in active form would contribute to stabilizing the CD146/moesin/RhoGDI1 complex.
Taken together, these data suggested that moesin mediates an indirect association of RhoGDI1 with CD146 cytoplasmic tail.
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As shown in Figure 8b , overexpression of CD146 in A375 cells apparently induced subcellular translocation of RhoGDI1 from the cytoplasm to the membrane (comparing the cell expressing both RhoGDI1-GFP and CD146-RFP with the one expressing only RhoGDI1-GFP). We further confirmed this biochemically by showing the increase of RhoGDI1 in the insoluble fraction of cell lysate upon CD146 overexpression, and found that active moesin is required for the translocation of RhoGDI1 to the membrane (Figure 8e) . These results supported the recruitment of RhoGDI1 by CD146/moesin complex. The subsequent question was how the formation of CD146/moesin/RhoGDI1 ternary complex affected the activity of RhoA. In A375 cells transfected with empty vectors, RhoGDI1 was found retained in a complex with RhoA; however, RhoGDI1 was no longer associated with RhoA upon ectopic expression of CD146 (Figure 8f ). Importantly, CD146 mutant without the moesin-binding KKGK motif was unable to sequester RhoGDI1 from RhoA, bolstering further that the binding of moesin to CD146 is crucial for sheltering RhoGDI1 in a membrane-linked complex and preventing the inhibitory association of RhoGDI1 with RhoA.
We then co-expressed RhoGDI1 with CD146 in A375 cells and examined the transmigration capacities of cancer cells. Under the overexpression of RhoGDI1, CD146 was not able to promote cell migration any longer (Figure 8g ). We reasoned that the ability of CD146 to recruit RhoGDI1 to the membrane was limited. Thus, ectopically expressed RhoGDI1 proteins could not be completely pulled out from the cytosolic pool, and the remaining RhoGDI1 was able to inhibit endogenous RhoA activity, resulting in compromised cell motility. The prevention of CD146-induced cell movements by increased level of RhoGDI1 indicated that regulating the subcellular localization of RhoGDI1 is an essential step of CD146 signaling cascade during cytoskeleton remodeling. To sum up, the functional consequences of forming CD146/moesin/RhoGDI1 heterotrimer are the release of RhoA activity from RhoGDI1-mediated inhibition, and the subsequent enhancement of cell migration mediated by activated RhoA.
Discussion
CD146 overexpression has been shown correlated with metastatic potential of human melanoma and capable of promoting cancer cell migration and invasion in both clinical studies and laboratory experiments (Bani et al., 1996; Shih et al., 1997; Xie et al., 1997) . However, the exact mechanism of how CD146 is involved in cell movements still remains largely unknown. Here, in human melanoma cells we uncovered the association between CD146 and ERM proteins, which leads to cytoskeleton remodeling and eventually cell migration mainly by two ways. First, ERM proteins, serving as adaptors, link membrane CD146 to actin filaments, which gives rise to local cytoskeleton rearrangement and promotes the formation of specific cell protrusions, such as microvilli and filopodia. Second, the interaction of CD146 with ERM proteins induces the activation of RhoA by recruiting RhoGDI to the CD146/ERM complex and sequestering it from RhoA spatially. Release of RhoA from the inhibitory interaction with RhoGDI results in upregulated RhoA activity, which then triggers various downstream signaling, contributing to global microfilament reorganizations. One of these signal events is the activation of PI4P5K-PIP 2 pathway, which induces further phosphorylation and activation of ERM proteins, forming a positive feedback loop to reinforce the association between CD146 and ERM proteins. The model we proposed here provides a novel mechanism of CD146 promoting melanoma cell migration.
On the basis of our observations that CD146 induces the formation and elongation of microvilli by recruiting ERM proteins and actin filaments, we propose that cell protrusion-enriched CD146 in collaboration with activated ERM proteins mediates the local cytoskeleton remodeling and microvillar development in specific membrane regions at the leading edge of the cell during cell migration. This notion is supported by recent discoveries that upon a gradient of CXCL12 concentrations CD146 could be polarly redistributed to mediate Wnt5a-controlled melanoma cell polarity and directional movement (Witze et al., 2008) . A similar CD146-actin-myosin polarity structure was also found asym- CD146 interacts with ERM in cell migration Y Luo et al metrically accumulated in the cell periphery under the treatment of CXCL12 gradient. Our studies close the gap between CD146 and actin filament and further bolster the idea that in response to chemokines CD146 can be first polarized in the direction of membrane extension, and then serves as an organizer to recruit cytoskeleton and motor proteins to specialized domains of the differentiated membrane. These molecular events cause local cytoskeleton rearrangement, cell protrusion formation, microvilli elongation, polarized membrane growth and eventually directional cell movement.
It is of great interest that CD146 not only recruits ERM proteins, but also induces ERM phosphorylation and activation. Previous studies have identified two steps for stable activation of ERM proteins (Niggli and Rossy, 2008) . ERM proteins first interact via their N-terminal FERM domain with the membrane PIP 2 . Subsequently, kinases, such as protein kinase C and ROCK, catalyze the C-terminal phosphorylation on a conserved threonine residue, which results in disruption of the intramolecular associations and exposure of NT domain. Our study found that RhoA-PI4P5K pathway, which upregulates the PIP 2 level, is essential for both endogenous CD146/ERM association and CD146 overexpression-induced ERM activation. However, Rho-activated ROCK is not responsible for ERM phosphorylation in human melanoma cells, indicating the function of ROCK as a kinase for the Thr residue of ERM proteins might depend on cell types (Hebert et al., 2008) . Moreover, various specific inhibitors against protein kinase Cs (BIM and Go¨6976), PI3-kinase (LY294002) or p38 mitogen-activated protein kinase (SB203580) have no significant effect on ERM activation and cell morphology (data not shown), suggesting that some unidentified enzymes might be involved in catalyzing Thr phosphorylation of ERM CT domain in human melanoma cells. Nevertheless, CD146-induced increase of PIP 2 level raises more phosphorylated and activated ERM proteins, which strengthen the connection between CD146 and actin filament, reinforcing cytoskeleton rearrangement in an auto-regulatory manner.
Another surprising discovery in this study is that except for serving as a docking site for F-actin, CD146-bound ERMs also initiate a signaling cascade to activate RhoA by releasing it from the inhibitory interaction with RhoGDI. In melanoma cells, in response to ectopic expression of CD146, RhoGDI is recruited and then sequestered in a CD146/moesin/RhoGDI ternary complex by its interaction with the NT domain of ERM proteins, which leads to the dissociation of RhoA from GDI and subsequent conversion of inactive RhoA-GDP to active RhoA-GTP by guanine nucleotide exchange factors on the membrane. Actually the exactly same mechanism was also found previously in ERM-CD44 system in vitro (Takahashi et al., 1997) , indicating that membrane receptor-bound ERM proteins may have a general activity to sequester GDI and activate Rho GTPase. As the function of RhoA in regulating cytoskeleton reorganization and promoting cell migration had been validated before in melanoma cells Bartolome et al., 2008; Molina-Ortiz et al., 2009) , CD146-inducing RhoA activation could upregulate the global capability of remodeling cell scaffolding and promoting cell movements. On the basis of these findings, our studies provide a mechanistic view for the correlation between CD146 overexpression and increased cell motility in human melanoma and may offer therapeutic targets for preventing cancer metastasis.
Materials and methods
Antibodies and reagents
The following antibodies were used in this study: anti-CD146 rabbit polyclonal antibody, mAb AA1 and AA14 (generated in our laboratory), anti-FLAG (clone M2), anti-His-tag, and anti-b-actin (Sigma-Aldrich, St Louis, MO, USA), anti-PI4P5K, anti-Myc (9E10) and anti-RhoGDI1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-GFP and anti-ERM 38/87 (Abcam, Cambridge, MA, USA), anti-phospho-ERM, and anti-RhoA (Cell Signaling, Danvers, MA, USA), horseradish peroxidase-conjugated anti-mouse and anti-rabbit secondary antibodies (GE Healthcare, Piscataway, NJ, USA). All western blots were carried out using enhanced SuperSignal West Dura (Pierce, Rockford, IL, USA). The inhibitors used were 10 mM Y27632 (Sigma-Aldrich), 1 mM neomycin (SigmaAldrich) and 1 mg/ml cell-permeable Rho inhibitor the exoenzyme C3-transferase (Cytoskeleton, Denver, CO, USA).
Plasmids and siRNA duplex Flag-CD146 and Myc-CD146 has been described previously (Zheng et al., 2009) . The Flag-CD146-KKGKLP, Flag-CD146-DKKGK and GST-CD146cyt mutants were generated by a polymerase chain reaction-based approach using Flag-CD146 as a template. WT Flag-ezrin, Flag-radixin, Flag-moesin, GFP-moesin, CFP-moesin, Myc-moesin, His-moesin-FERM (residues 1-320), Flag-moesin-FERM and GST-RBD were generated by a polymerase chain reaction-based approach using A375 cell cDNA as a template. Flag-moesin-T558A and Flagmoesin-T558D were generated by site-directed mutagenesis using WT Flag-moesin as a template. CFP-moesin-T558A, CFP-moesin-T558D and CFP-moesin-FERM mutants were generated by replacing WT CFP-moesin with the corresponding fragments of Flag-moesin-T558A, Flag-moesin-T558D and Flag-moesin-FERM. Flag-RhoA, Myc-RhoGDI1 and GFPRhoGDI1 were generated by a polymerase chain reactionbased approach using A375 cell cDNA as a template. FlagRhoA-19N was generated by site-directed mutagenesis using WT Flag-RhoA as a template. The fidelity and appropriate mutations of all the constructs generated were confirmed by sequencing.
The synthetic siRNA duplex targeting PI4P5K1 were generated according to the sequences reported previously (Lacalle et al., 2007; Barrero-Villar et al., 2008) . The synthetic small interfering RNA duplexes targeting CD146 and GFP control, respectively, were synthesized at Invitrogen (San Diego, CA, USA) using the sequences reported previously (Zheng et al., 2009) . The efficacy of gene silencing was analyzed by immunoblotting and found to be optimal at 24 h after siRNA transfection.
Cells and transfection
Human melanoma cell lines A375, SK-mel-28 and Mel-624 were obtained from American Type Culture Collection (Rockville, MD, USA). A375, Mel-624 and SK-mel-28 are CD146 interacts with ERM in cell migration Y Luo et al natively CD146-expressing cells, whereas Mel-888 CD146 was a stably transfected CD146-expressing cell line. All cell lines were cultured in Dulbecco's modified Eagle medium supplemented with 10% fetal calf serum and antibiotics (Gibco Life Technologies Inc., Paisley, UK). All cultures were performed in 5% CO 2 humidified atmosphere at 37 1C. Cells were cultured on glass coverslips pretreated with 50 mg/ml poly-Llysine for fluorescence microscopy studies. The Lipofectamine 2000 reagent-(Invitrogen) mediated transfection was performed according to the manufacturer's instructions.
Immunoprecipitation
Cells were lysed with radioimmunoprecipitation assay buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 0.1% sodium dodecyl sulfate (SDS), 0.5% deoxycholate, 1% NP-40, 1 mM phenylmethanesulfonyl fluoride and Protease Inhibitor Cocktails (Roche, Indianapolis, IN, USA)) for 0.5 h on ice. After centrifugation, the soluble supernatants were pre-cleared with protein G PLUS-Agarose (Santa Cruz Biotechnology Inc.). Samples were then immunoprecipitated with specific antibodies and 25 ml of protein G-agarose beads. Protein G-bound immunocomplexes were extensively washed with radioimmunoprecipitation assay washing buffer (150 mM NaCl, 50 mM Tris, pH 8.0, 0.1% SDS, 0.5% deoxycholate, 0.1% NP-40, 1 mM phenylmethanesulfonyl fluoride and Protease Inhibitor Cocktails) and boiled in sample loading buffer for SDSpolyacrylamide gel electrophoresis. The immunoprecipitated proteins were detected by western blot.
To identify potential CD146-associated proteins, 1 ml of lysate from 6 Â 10 6 A375 cells was prepared and immunoprecipitated with anti-CD146 mAb AA98. Proteins bound to protein G-agarose beads were separated by 10% SDSpolyacrylamide gel electrophoresis and stained with Coomassie blue, and proteins specifically associated with CD146 was analyzed using mass spectrometry.
Immunoblot analysis
For immunoblot, proteins were resolved with 10% SDSpolyacrylamide gel electrophoresis and then transferred to a nitrocellulose membrane (Amersham, Piscataway, NJ, USA). The membranes were blocked with 5% non-fat milk in phosphate-buffered saline with 0.1% Tween-20 for 2 h, incubated for 2 h with primary antibodies and then probed with horseradish peroxidase-conjugated anti-mouse or antirabbit secondary antibodies. All immunoblots were carried out using chemiluminescence reagent (Pierce) and exposed to X-ray films (Kodak, New York, NY, USA).
In vitro GST pull-down assay In all, 0.15 mg GST or GST-CD146cyt expressed in Escherichia coli was absorbed on glutathione agarose beads (SigmaAldrich). The beads were then incubated with 0.15 mg purified moesin-FERM-His protein for 1 h in the presence or absence of anti-CD146 mAbs. Proteins bound to the beads were then boiled in sample loading buffer and subjected to immunoblot.
Treating living cells with inhibitors A375 cells cultured to 70-80% confluence were incubated with or without 1 mg/ml C3 transferase, 10 mM Y27632 and 1 mM neomycin, for 6, 12 and 48 h, respectively. To compare the amounts of soluble and insoluble ERM proteins, cells were homogenized in a physiological solution (130 mM KCl, 20 mM NaCl, 1 mM MgCl 2 , 10 mM Hepes, pH 7.5, 1 mM phenylmethanesulfonyl fluoride and Protease Inhibitor Cocktails). After centrifugation at 300 000 g for 20 min, the amount of ERM proteins in pellet and supernatant was quantified by immunoblot using anti-ERM 38/87. At least three independent experiments were performed. In addition, cells under the same treatments were also lysed and then immunoprecipitated with anti-CD146 mAb AA1, and the precipitates were separated by SDS-polyacrylamide gel electrophoresis followed by immunoblot with anti-ERM 38/87.
Pull-down assay for the determination of RhoA activation Cells were lysed in 600 ml radioimmunoprecipitation assay buffer, and an aliquot of lysate (90 ml) was saved to test the total protein expression after centrifugation. The rest of lysates were incubated with GST-RBD (20 mg) beads at 4 1C for 45 min. Beads were washed four times with wash buffer (50 mM Tris, pH 7.6, 1% Triton X-100, 500 mM NaCl, 50 mM MgCl 2 , 0.1 mM phenylmethanesulfonyl fluoride and Protease Inhibitor Cocktails). Bound Rho proteins were detected by immunoblot using an mAb against RhoA (Cell Signaling Technology). The amount of RBD-bound RhoA was normalized to the total amount of RhoA in cell lysates for the comparison of RhoA activity (level of GTP-bound RhoA) in different samples. At least three independent experiments were performed.
Immunofluorescence
For immunofluorescent staining, A375 cells were plated on coverslips. After transfections, the cells were washed with phosphate-buffered saline, fixed in 4% paraformaldehyde/ phosphate-buffered saline, permeabilized with 0.2% Triton X-100/phosphate-buffered saline and incubated with the indicated primary antibody, followed by incubation with FITCconjugated anti-mouse immunoglobulin G or anti-rabbit immunoglobulin GG (Invitrogen). F-actin was stained by Alexa Fluor 488 phalloidin (Invitrogen) for 20 min at room temperature. Samples were examined with a confocal laser scanning microscope (Olympus, Tokyo, Japan).
Cell migration assay
Cell migration capabilities were assayed using Transwell (8-mm pore filters; Corning Costar, Lowell, MA, USA). Before migration, cells were serum-starved overnight. Then, 2.0 Â 10 5 cells in 50 ml serum-free Dulbecco's modified Eagle's medium were added into the upper chamber, and 200 ml Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum was added to the lower chamber. Cells were allowed to migrate for 48 h at 37 1C. After removing cells on the upper surface of the filter using cotton swabs, cells that invaded through the membrane were fixed with 4% paraformaldehyde and stained with 0.1% crystal violet solution. The number of cells that reached the lower part of the Transwell filter membrane was counted and plotted as the number of cells per optic field ( Â 4). Experiments were carried out in triplicate.
Statistical analysis
All values are representative of experiments performed in triplicate. The graphical results are expressed as the mean±s.d. Paired t-test methods were used to compare differences between groups in various experiments. The criterion for statistical significance is defined as Po0.05.
Abbreviations
ERM proteins, ezrin-radixin-moesin proteins; PIP 2 , phosphatidylinositol 4,5-biphosphate; RBD, Rho-binding domain; RhoGDI1, Rho guanine nucleotide dissociation inhibitory factors 1; ROCK, Rho-associated coiled-coil protein kinase.
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